feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / FutureCure Raises $11.5M for Vertigo Care Expansion

FutureCure Raises $11.5M for Vertigo Care Expansion

6 Jan

•

Summary

  • FutureCure Health secured Rs 104 crore funding led by Carnelian Asset Management.
  • The company aims to expand access to vertigo diagnosis and treatment.
  • NeuroEquilibrium, a subsidiary, uses tech to bridge specialist doctor shortages.
FutureCure Raises $11.5M for Vertigo Care Expansion

FutureCure Health, a healthcare technology firm specializing in super-speciality care, has successfully secured Rs 104 crore ($11.5 million) in a recent funding round. The investment was spearheaded by Carnelian Asset Management LLP, with contributions from other investors, bolstering the company's mission to enhance healthcare accessibility.

These newly acquired funds are earmarked for significant expansion, particularly in making vertigo diagnosis and treatment more widely available. FutureCure operates NeuroEquilibrium, a wholly-owned subsidiary that runs specialized clinics for dizziness and vertigo. This chain focuses on identifying the root causes of vertigo, employing advanced diagnostics and cloud-based remote platforms to deliver precise care.

The company's innovative approach tackles a global shortage of neuro-otology specialists. By integrating deep-tech, FutureCure aims to scale precision medicine beyond urban centers and expand into areas like migraine and diabetes management, ultimately democratizing specialized healthcare.

trending

Grateful Dead's Bob Weir dies

trending

NFL playoff bracket updated

trending

Lightning beat Flyers 7-2

trending

NFL playoffs wild card weekend

trending

Yeison Jiménez plane accident

trending

Pacers beat Miami Heat

trending

Bears stun Green Bay Packers

trending

Hornets rout Jazz 150-95

trending

Sabres beat Ducks, win streak

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
FutureCure Health focuses on super-speciality care, particularly in diagnosing and treating vertigo and dizziness through its subsidiary NeuroEquilibrium.
FutureCure Health recently raised Rs 104 crore ($11.5 million) in a funding round led by Carnelian Asset Management.
NeuroEquilibrium identifies the root cause of vertigo, whether from the inner ear, brain, or balance pathways, enabling targeted treatment using advanced diagnostics and technology.

Read more news on

Business and Economyside-arrow

You may also like

Medical Education Evolves: NCDs, AI, and Climate Change Take Center Stage

1 day ago • 16 reads

article image

Foresite Capital Dumps Edgewise Therapeutics Stake

30 Dec, 2025 • 25 reads

article image

Asian Women Face Double Risk of Severe Birth Tears

26 Dec, 2025 • 86 reads

article image

India's Retirement Crisis: Longer Lives, Shorter Savings

15 Dec, 2025 • 122 reads

article image

Elderly Dementia Patient Loses Vital Funding

8 Dec, 2025 • 148 reads

article image